U.S. actor Michael Douglas begins chemotherapy after doctors discover a tumor in his throat.
The United States Food and Drug Administration approves marketing of a cooling cap system to reduce hair loss in female breast cancer patients during chemotherapy. The DigniCap scalp cooling system, a product first available in Sweden in the 1990s, produces near-freezing temperatures that make it harder for cancer-fighting drugs to reach and harm hair follicles. [https:--www.usnews.com-news-politics-articles-2015-12-08-fda-clears-cold-cap-to-save-hair-during-breast-cancer-chemo (AP via U.S. News and World Report)] [http:--www.fda.gov-NewsEvents-Newsroom-PressAnnouncements-ucm476216.htm (FDA)] [http:--www.dignicap.com-dignitana-fda-clearance- (DigniCap)]date=August 2019
Panels of the United States Fourth and D.C. ("Halbig v. Burwell") Circuit Courts make contradictory rulings as to whether people who enroll in federal exchanges under the Affordable Care Act (Obamacare) can receive subsidies.